---
schema_version: "secwatch.filing_event.v1"
accession: "0000937556-24-000040"
form_type: "8-K"
ticker: "MASI"
cik: "0000937556"
company_name: "MASIMO CORP"
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T21:34:52.099579+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Masimo Q1 rev $492.8M (healthcare $339.6M), GAAP EPS $0.35, Non-GAAP $0.77; lifts FY2024 outlook

## Summary
- Consolidated Q1 revenue $492.8M; healthcare $339.6M, non-healthcare $153.2M.
- GAAP net income $18.9M ($0.35 diluted EPS); non-GAAP net income $41.9M ($0.77 diluted EPS).
- Sensor manufacturing shift from Mexico to Malaysia improved healthcare gross margins ahead of schedule.
- Raises FY2024 healthcare revenue guidance to $1.355-1.385B and non-GAAP EPS to $3.54-3.70.
- Pursuing separation of consumer business; management finalizing structure for board review.

## SEC filing metadata
- accession: 0000937556-24-000040
- form_type: 8-K
- ticker: MASI
- cik: 0000937556
- company_name: MASIMO CORP
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/937556/000093755624000040/0000937556-24-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/937556/000093755624000040/masi-20240507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000937556-24-000040
- JSON: https://secwatch.observer/filing/0000937556-24-000040.json
- Plain text: https://secwatch.observer/filing/0000937556-24-000040.txt

## Key facts
- Earnings Releases
  MASIMO CORP reported first quarter ended March 30, 2024 results: revenue $492.8 million, net income $18.9 million, EPS $0.35 per diluted share. Guidance raised.
  - Period: first quarter ended March 30, 2024
  - Revenue: $492.8 million
  - Net income: $18.9 million
  - EPS: $0.35 per diluted share
  - Guidance: raised
  - Result: reported results
  source text: by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Masimo Reports First Quarter 2024 Financial Results First Quarter 2024 Highlights: • Consolidated revenue was $492.8 million; • Healthcare revenue was $339.6 million; • Non-healthcare revenue was $153.2 million; • GAAP net income per diluted share was $0.35; and • Non-GAAP net income per diluted share
  evidence_url: https://www.sec.gov/Archives/edgar/data/937556/000093755624000040/0000937556-24-000040-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.